538 related articles for article (PubMed ID: 16723399)
1. Epigenetic inactivation of the premature aging Werner syndrome gene in human cancer.
Agrelo R; Cheng WH; Setien F; Ropero S; Espada J; Fraga MF; Herranz M; Paz MF; Sanchez-Cespedes M; Artiga MJ; Guerrero D; Castells A; von Kobbe C; Bohr VA; Esteller M
Proc Natl Acad Sci U S A; 2006 Jun; 103(23):8822-7. PubMed ID: 16723399
[TBL] [Abstract][Full Text] [Related]
2. Role for the Werner syndrome protein in the promotion of tumor cell growth.
Opresko PL; Calvo JP; von Kobbe C
Mech Ageing Dev; 2007; 128(7-8):423-36. PubMed ID: 17624410
[TBL] [Abstract][Full Text] [Related]
3. Association of epigenetic inactivation of the WRN gene with anticancer drug sensitivity in cervical cancer cells.
Masuda K; Banno K; Yanokura M; Tsuji K; Kobayashi Y; Kisu I; Ueki A; Yamagami W; Nomura H; Tominaga E; Susumu N; Aoki D
Oncol Rep; 2012 Oct; 28(4):1146-52. PubMed ID: 22797812
[TBL] [Abstract][Full Text] [Related]
4. WRN helicase defective in the premature aging disorder Werner syndrome genetically interacts with topoisomerase 3 and restores the top3 slow growth phenotype of sgs1 top3.
Aggarwal M; Brosh RM
Aging (Albany NY); 2009 Feb; 1(2):219-33. PubMed ID: 20157511
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic loss of the familial tumor-suppressor gene exostosin-1 (EXT1) disrupts heparan sulfate synthesis in cancer cells.
Ropero S; Setien F; Espada J; Fraga MF; Herranz M; Asp J; Benassi MS; Franchi A; Patiño A; Ward LS; Bovee J; Cigudosa JC; Wim W; Esteller M
Hum Mol Genet; 2004 Nov; 13(22):2753-65. PubMed ID: 15385438
[TBL] [Abstract][Full Text] [Related]
6. Role of Werner syndrome gene product helicase in carcinogenesis and in resistance to genotoxins by cancer cells.
Futami K; Ishikawa Y; Goto M; Furuichi Y; Sugimoto M
Cancer Sci; 2008 May; 99(5):843-8. PubMed ID: 18312465
[TBL] [Abstract][Full Text] [Related]
7. The Werner syndrome protein contributes to induction of p53 by DNA damage.
Blander G; Zalle N; Leal JF; Bar-Or RL; Yu CE; Oren M
FASEB J; 2000 Nov; 14(14):2138-40. PubMed ID: 11023999
[TBL] [Abstract][Full Text] [Related]
8. Werner syndrome as a hereditary risk factor for exocrine pancreatic cancer: potential role of WRN in pancreatic tumorigenesis and patient-tailored therapy.
Chun SG; Yee NS
Cancer Biol Ther; 2010 Sep; 10(5):430-7. PubMed ID: 20657174
[TBL] [Abstract][Full Text] [Related]
9. Preferential expression of an intact WRN gene in Werner syndrome cell lines in which a normal chromosome 8 has been introduced.
Kashino G; Kodama S; Suzuki K; Oshimura M; Watanabe M
Biochem Biophys Res Commun; 2001 Nov; 289(1):111-5. PubMed ID: 11708785
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic gene silencing in cancer: the DNA hypermethylome.
Esteller M
Hum Mol Genet; 2007 Apr; 16 Spec No 1():R50-9. PubMed ID: 17613547
[TBL] [Abstract][Full Text] [Related]
11. Werner syndrome protein limits MYC-induced cellular senescence.
Grandori C; Wu KJ; Fernandez P; Ngouenet C; Grim J; Clurman BE; Moser MJ; Oshima J; Russell DW; Swisshelm K; Frank S; Amati B; Dalla-Favera R; Monnat RJ
Genes Dev; 2003 Jul; 17(13):1569-74. PubMed ID: 12842909
[TBL] [Abstract][Full Text] [Related]
12. Genetic cooperation between the Werner syndrome protein and poly(ADP-ribose) polymerase-1 in preventing chromatid breaks, complex chromosomal rearrangements, and cancer in mice.
Lebel M; Lavoie J; Gaudreault I; Bronsard M; Drouin R
Am J Pathol; 2003 May; 162(5):1559-69. PubMed ID: 12707040
[TBL] [Abstract][Full Text] [Related]
13. The Werner syndrome gene: the molecular basis of RecQ helicase-deficiency diseases.
Shen JC; Loeb LA
Trends Genet; 2000 May; 16(5):213-20. PubMed ID: 10782115
[TBL] [Abstract][Full Text] [Related]
14. A novel Werner Syndrome mutation: pharmacological treatment by read-through of nonsense mutations and epigenetic therapies.
Agrelo R; Sutz MA; Setien F; Aldunate F; Esteller M; Da Costa V; Achenbach R
Epigenetics; 2015; 10(4):329-41. PubMed ID: 25830902
[TBL] [Abstract][Full Text] [Related]
15. Increased frequency of DNA deletions in pink-eyed unstable mice carrying a mutation in the Werner syndrome gene homologue.
Lebel M
Carcinogenesis; 2002 Jan; 23(1):213-6. PubMed ID: 11756244
[TBL] [Abstract][Full Text] [Related]
16. The Werner syndrome protein: an update.
Oshima J
Bioessays; 2000 Oct; 22(10):894-901. PubMed ID: 10984715
[TBL] [Abstract][Full Text] [Related]
17. Werner syndrome protein prevents DNA breaks upon chromatin structure alteration.
Turaga RV; Massip L; Chavez A; Johnson FB; Lebel M
Aging Cell; 2007 Aug; 6(4):471-81. PubMed ID: 17521388
[TBL] [Abstract][Full Text] [Related]
18. Werner protein stimulates topoisomerase I DNA relaxation activity.
Laine JP; Opresko PL; Indig FE; Harrigan JA; von Kobbe C; Bohr VA
Cancer Res; 2003 Nov; 63(21):7136-46. PubMed ID: 14612507
[TBL] [Abstract][Full Text] [Related]
19. WRN mutations in Werner syndrome.
Moser MJ; Oshima J; Monnat RJ
Hum Mutat; 1999; 13(4):271-9. PubMed ID: 10220139
[TBL] [Abstract][Full Text] [Related]
20. Cellular Werner phenotypes in mice expressing a putative dominant-negative human WRN gene.
Wang L; Ogburn CE; Ware CB; Ladiges WC; Youssoufian H; Martin GM; Oshima J
Genetics; 2000 Jan; 154(1):357-62. PubMed ID: 10628995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
